Titre : Motifs EF Hands

Motifs EF Hands : Questions médicales fréquentes

Termes MeSH sélectionnés :

Virtual Reality
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Motifs EF Hands : Questions médicales les plus fréquentes", "headline": "Motifs EF Hands : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Motifs EF Hands : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-19", "dateModified": "2025-03-14", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Motifs EF Hands" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Motifs à hélice-boucle-hélice", "url": "https://questionsmedicales.fr/mesh/D018257", "about": { "@type": "MedicalCondition", "name": "Motifs à hélice-boucle-hélice", "code": { "@type": "MedicalCode", "code": "D018257", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G02.111.570.820.709.275.500.360" } } }, "about": { "@type": "MedicalCondition", "name": "Motifs EF Hands", "alternateName": "EF Hand Motifs", "code": { "@type": "MedicalCode", "code": "D020832", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Peter B Stathopulos", "url": "https://questionsmedicales.fr/author/Peter%20B%20Stathopulos", "affiliation": { "@type": "Organization", "name": "Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada." } }, { "@type": "Person", "name": "Qi-Tong Lin", "url": "https://questionsmedicales.fr/author/Qi-Tong%20Lin", "affiliation": { "@type": "Organization", "name": "Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada." } }, { "@type": "Person", "name": "Biraj B Kayastha", "url": "https://questionsmedicales.fr/author/Biraj%20B%20Kayastha", "affiliation": { "@type": "Organization", "name": "Department of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK, 74078, USA." } }, { "@type": "Person", "name": "Aya Kubo", "url": "https://questionsmedicales.fr/author/Aya%20Kubo", "affiliation": { "@type": "Organization", "name": "Department of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK, 74078, USA." } }, { "@type": "Person", "name": "Jacob Burch-Konda", "url": "https://questionsmedicales.fr/author/Jacob%20Burch-Konda", "affiliation": { "@type": "Organization", "name": "Department of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK, 74078, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Virtual docking screening and quantitative structure-activity relationship studies to explore AKT and PI3K inhibitors acting on mTOR in cancers by theoretical biology and medical modeling.", "datePublished": "2023-12-13", "url": "https://questionsmedicales.fr/article/38239868", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.5114/wo.2023.133709" } }, { "@type": "ScholarlyArticle", "name": "Discovery of 3-oxo-1,2,3,4-tetrahydropyrido[1,2-a]pyrazin derivatives as SARS-CoV-2 main protease inhibitors through virtual screening and biological evaluation.", "datePublished": "2023-11-08", "url": "https://questionsmedicales.fr/article/37944867", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.bmcl.2023.129547" } }, { "@type": "ScholarlyArticle", "name": "Suicide and Self-Harm in Adolescents During the COVID-19 Pandemic: A U.S. Virtual Pediatric Systems, LLC, Database Study of PICU Admissions, 2016-2021.", "datePublished": "2023-10-09", "url": "https://questionsmedicales.fr/article/37812055", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/PCC.0000000000003381" } }, { "@type": "ScholarlyArticle", "name": "Use of Massive Online Open Courses (MOOCs) model in virtual education development in first macro-region universities of medical sciences in countrywide territorial planning.", "datePublished": "2023-09-29", "url": "https://questionsmedicales.fr/article/38023067", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.4103/jehp.jehp_1221_22" } }, { "@type": "ScholarlyArticle", "name": "Value of placental virtual magnetic resonance elastography and intravoxel incoherent motion-based diffusion and perfusion in predicting adverse outcomes of small-for-gestational-age infants.", "datePublished": "2023-09-23", "url": "https://questionsmedicales.fr/article/37741945", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13244-023-01503-9" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes chimiques", "item": "https://questionsmedicales.fr/mesh/D055598" }, { "@type": "ListItem", "position": 3, "name": "Phénomènes biochimiques", "item": "https://questionsmedicales.fr/mesh/D001669" }, { "@type": "ListItem", "position": 4, "name": "Conformation moléculaire", "item": "https://questionsmedicales.fr/mesh/D008968" }, { "@type": "ListItem", "position": 5, "name": "Conformation des protéines", "item": "https://questionsmedicales.fr/mesh/D011487" }, { "@type": "ListItem", "position": 6, "name": "Éléments structuraux des protéines", "item": "https://questionsmedicales.fr/mesh/D000072416" }, { "@type": "ListItem", "position": 7, "name": "Motifs à hélice-boucle-hélice", "item": "https://questionsmedicales.fr/mesh/D018257" }, { "@type": "ListItem", "position": 8, "name": "Motifs EF Hands", "item": "https://questionsmedicales.fr/mesh/D020832" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Motifs EF Hands - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Motifs EF Hands", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-03", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Motifs EF Hands", "description": "Comment diagnostiquer un motif EF Hand ?\nQuels tests sont utilisés pour les motifs EF Hands ?\nLes motifs EF Hands sont-ils visibles par imagerie ?\nPeut-on identifier des mutations dans les motifs EF Hands ?\nQuel rôle joue la bioinformatique dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D020832?mesh_terms=Virtual+Reality&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Motifs EF Hands", "description": "Quels symptômes sont associés aux motifs EF Hands ?\nLes motifs EF Hands sont-ils liés à des maladies ?\nComment les motifs EF Hands affectent-ils la signalisation cellulaire ?\nY a-t-il des signes cliniques de dysfonction des motifs EF Hands ?\nLes motifs EF Hands influencent-ils le métabolisme ?", "url": "https://questionsmedicales.fr/mesh/D020832?mesh_terms=Virtual+Reality&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Motifs EF Hands", "description": "Peut-on prévenir les anomalies des motifs EF Hands ?\nY a-t-il des facteurs environnementaux à considérer ?\nComment le stress influence-t-il les motifs EF Hands ?\nL'exercice physique a-t-il un impact sur ces motifs ?\nLes suppléments de calcium sont-ils bénéfiques ?", "url": "https://questionsmedicales.fr/mesh/D020832?mesh_terms=Virtual+Reality&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Motifs EF Hands", "description": "Quels traitements ciblent les motifs EF Hands ?\nPeut-on modifier les motifs EF Hands par thérapie génique ?\nLes médicaments peuvent-ils influencer les motifs EF Hands ?\nY a-t-il des approches expérimentales pour traiter les anomalies ?\nComment la nutrition peut-elle influencer les motifs EF Hands ?", "url": "https://questionsmedicales.fr/mesh/D020832?mesh_terms=Virtual+Reality&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Motifs EF Hands", "description": "Quelles complications peuvent survenir avec des motifs EF Hands défectueux ?\nLes motifs EF Hands sont-ils liés à des cancers ?\nComment les complications affectent-elles la qualité de vie ?\nY a-t-il des risques de maladies cardiovasculaires ?\nLes complications sont-elles réversibles ?", "url": "https://questionsmedicales.fr/mesh/D020832?mesh_terms=Virtual+Reality&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Motifs EF Hands", "description": "Quels sont les facteurs de risque pour les anomalies des motifs EF Hands ?\nL'âge influence-t-il les motifs EF Hands ?\nLe mode de vie joue-t-il un rôle dans les risques ?\nLes antécédents familiaux sont-ils un facteur de risque ?\nLes infections peuvent-elles affecter les motifs EF Hands ?", "url": "https://questionsmedicales.fr/mesh/D020832?mesh_terms=Virtual+Reality&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un motif EF Hand ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des analyses biochimiques et des études de structure protéique." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour les motifs EF Hands ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques comme la spectroscopie RMN et la cristallographie aux rayons X sont utilisées." } }, { "@type": "Question", "name": "Les motifs EF Hands sont-ils visibles par imagerie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, ils nécessitent des méthodes biochimiques pour être étudiés, pas d'imagerie classique." } }, { "@type": "Question", "name": "Peut-on identifier des mutations dans les motifs EF Hands ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des techniques de séquençage génétique peuvent révéler des mutations affectant ces motifs." } }, { "@type": "Question", "name": "Quel rôle joue la bioinformatique dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "La bioinformatique aide à prédire la structure et la fonction des motifs EF Hands." } }, { "@type": "Question", "name": "Quels symptômes sont associés aux motifs EF Hands ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les motifs EF Hands ne présentent pas de symptômes directs, mais affectent des fonctions cellulaires." } }, { "@type": "Question", "name": "Les motifs EF Hands sont-ils liés à des maladies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans ces motifs peuvent être associées à des maladies comme l'ataxie." } }, { "@type": "Question", "name": "Comment les motifs EF Hands affectent-ils la signalisation cellulaire ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils régulent la signalisation calcique, influençant divers processus cellulaires." } }, { "@type": "Question", "name": "Y a-t-il des signes cliniques de dysfonction des motifs EF Hands ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des signes indirects peuvent apparaître, comme des troubles neurologiques ou musculaires." } }, { "@type": "Question", "name": "Les motifs EF Hands influencent-ils le métabolisme ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils jouent un rôle dans le métabolisme cellulaire en régulant le calcium." } }, { "@type": "Question", "name": "Peut-on prévenir les anomalies des motifs EF Hands ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est difficile, mais un mode de vie sain peut réduire les risques associés." } }, { "@type": "Question", "name": "Y a-t-il des facteurs environnementaux à considérer ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines peut affecter la fonction des motifs EF Hands." } }, { "@type": "Question", "name": "Comment le stress influence-t-il les motifs EF Hands ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Le stress peut perturber la signalisation calcique, affectant indirectement ces motifs." } }, { "@type": "Question", "name": "L'exercice physique a-t-il un impact sur ces motifs ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "L'exercice régule la signalisation calcique, ce qui peut soutenir la fonction des motifs." } }, { "@type": "Question", "name": "Les suppléments de calcium sont-ils bénéfiques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des suppléments peuvent aider à maintenir un bon équilibre calcique, soutenant la fonction." } }, { "@type": "Question", "name": "Quels traitements ciblent les motifs EF Hands ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de traitements spécifiques pour les motifs EF Hands." } }, { "@type": "Question", "name": "Peut-on modifier les motifs EF Hands par thérapie génique ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique pourrait potentiellement corriger des mutations affectant ces motifs." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils influencer les motifs EF Hands ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments modulent la signalisation calcique, indirectement affectant ces motifs." } }, { "@type": "Question", "name": "Y a-t-il des approches expérimentales pour traiter les anomalies ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des recherches sont en cours sur des peptides et des inhibiteurs ciblant les motifs EF Hands." } }, { "@type": "Question", "name": "Comment la nutrition peut-elle influencer les motifs EF Hands ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Une nutrition adéquate en calcium et en magnésium peut soutenir leur fonction." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des motifs EF Hands défectueux ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications peuvent inclure des troubles neurologiques et musculaires." } }, { "@type": "Question", "name": "Les motifs EF Hands sont-ils liés à des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent un lien potentiel entre des anomalies et certains types de cancer." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent entraîner des limitations fonctionnelles et des douleurs chroniques." } }, { "@type": "Question", "name": "Y a-t-il des risques de maladies cardiovasculaires ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des dysfonctionnements calciques peuvent contribuer à des maladies cardiovasculaires." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les anomalies des motifs EF Hands ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des prédispositions génétiques et des expositions environnementales." } }, { "@type": "Question", "name": "L'âge influence-t-il les motifs EF Hands ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut affecter la fonction des motifs EF Hands et la signalisation calcique." } }, { "@type": "Question", "name": "Le mode de vie joue-t-il un rôle dans les risques ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sédentaire et une mauvaise alimentation augmentent les risques." } }, { "@type": "Question", "name": "Les antécédents familiaux sont-ils un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de maladies génétiques peuvent augmenter le risque." } }, { "@type": "Question", "name": "Les infections peuvent-elles affecter les motifs EF Hands ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections peuvent perturber la signalisation calcique, affectant ces motifs." } } ] } ] }

Sources (10000 au total)

Virtual docking screening and quantitative structure-activity relationship studies to explore AKT and PI3K inhibitors acting on mTOR in cancers by theoretical biology and medical modeling.

The mechanistic target of rapamycin (mTOR) coordinates the growth and metabolism of eukaryotic cells with a central role in the regulation of many fundamental cellular processes. It is strongly connec... To explore the common competitive adenosine triphosphate (ATP) inhibitors PI3K/AKT and PI3K/mTOR, we built a 2D mTOR-SAR model that predicted the bioactivity of AKT and PI3K inhibitors towards mTOR. T... A mechanistic target of rapamycin-quantitative structure-activity relationship (mTOR-QSAR) model with a correlation coefficient (R... After docking and several comparisons, the inhibitors with better predictions showed better affinity and interaction with mTOR compared to AZ8055 and XL388, so we have found that 2 AKT inhibitors and ...

Suicide and Self-Harm in Adolescents During the COVID-19 Pandemic: A U.S. Virtual Pediatric Systems, LLC, Database Study of PICU Admissions, 2016-2021.

To characterize the epidemiology of suicide and self-harm among adolescents admitted to PICUs during the first 2 years of the COVID-19 pandemic in the United States.... Descriptive analysis of a large, multicenter, quality-controlled database (Virtual Pediatric Systems [VPS]), and of a national public health dataset (U.S. Centers for Disease Control and Prevention we... The 69 PICUs participating in the VPS database that contributed data for the entire the study period, January 1, 2016, to December 31, 2021.... Adolescents older than 12 years to younger than 18 years old admitted to a participating PICU during the study period with a diagnosis involving self-harm or a suicide attempt (VPS sample), or adolesc... None.... We identified 10,239 suicide deaths and 7,692 PICU admissions for self-harm, including 5,414 admissions in the pre-pandemic period (Q1-2016 to Q1-2020) and 2,278 in the pandemic period (Q2-2020 to Q4-... The number of suicide deaths and PICU admissions per quarter for self-harm remained relatively constant during the pandemic, while the number of all-cause PICU admissions per quarter decreased compare...

Use of Massive Online Open Courses (MOOCs) model in virtual education development in first macro-region universities of medical sciences in countrywide territorial planning.

Massive online open cources (MOOCs) are a new chapter in the topic of teaching-learning in higher education, which have been able to acquire a significant and valuable position in higher education and... This research is based on a mixed method and practical in terms of purpose, and it was carried out in 2021 and 2022 in first macro-region of countrywide regional planning Medical Sciences Universities... Universities are facing challenges in structural, managerial, cultural, social, technological, and evaluation dimensions, and the current situation of using MOOCs in them is not appropriate.... Besides, the analysis of the optimal situation of using MOOCs in these universities indicates that technological, structural, managerial, evaluation, educational, and personal dimensions are the most ...

Value of placental virtual magnetic resonance elastography and intravoxel incoherent motion-based diffusion and perfusion in predicting adverse outcomes of small-for-gestational-age infants.

It is critical to early monitor and manage small-for-gestational age (SGA) infants with truly adverse outcomes not detected by conventional methods. We aimed to explore the value of diffusion-weighted... Twenty SGA infants with adverse outcomes and forty without adverse outcomes were included in this prospective study. One DWI-based vMRE parameter [the stiffness value (μ... The placental μ... Functional MRI parameters to quantify placenta elastography and microcirculation in SGA patients. This might be a useful tool to assess placental function and a vital non-invasive supplement for predi... This prospective study shows DWI-based virtual magnetic resonance elastography and intravoxel incoherent motion-based functional parameters to quantify placenta elastography and microcirculation in sm... • vMRE is an emerging non-invasive imaging technique for evaluating placenta stiffness. • SGA infants with adverse outcome have stiffer placental elasticity and lower microcirculation. • Risk factors ...

Accuracy of intravascular ultrasound-derived virtual fractional flow reserve (FFR) and FFR derived from computed tomography for functional assessment of coronary artery disease.

Coronary computed tomography-derived fractional flow reserve (CT-FFR) and intravascular ultrasound-derived fractional flow reserve (IVUS-FFR) are two functional assessment methods for coronary stenose... Six hundred and seventy patients (698 lesions) with known or suspected coronary artery disease were screened for this retrospective analysis between January 2020 and July 2021. A total of 40 patients ... Both AccuFFRivus and AccuFFRct demonstrated a strong correlation with invasive FFR (R = 0.7913, P < 0.0001; and R = 0.6296, P < 0.0001), and both methods showed good agreement with FFR. The area under... AccuFFRivus, computed from IVUS images, exhibited a high diagnostic performance for detecting myocardial ischemia. It demonstrated better diagnostic power than AccuFFRct, and could serve as an accurat...

Can preoperative planning using IRIS™ three-dimensional anatomical virtual models predict operative findings during robot-assisted partial nephrectomy?

To evaluate the predictive validity of IRIS™ (Intuitive Surgical®, Sunnyvale, CA, USA) as a planning tool for robot-assisted partial nephrectomy (RAPN) by assessing the degree of overlap with intraope... Thirty-one patients scheduled for RAPN by four experienced urologists were enrolled in a prospective study. Prior to surgery, urologists reviewed the IRIS™ three-dimensional model on an iphone Operati... Mean age was 65.1 years with a mean tumor size of 27.7 mm (interquartile range 17.5-44.0 mm). Hilar tumors consisted of 32.3%; 48.4% of patients had R.E.N.A.L. nephrometry scores of 7-9. On preoperati... A high degree of overlap between the preoperative surgical approach and intraoperative RAPN execution was found using IRIS™. This is the first study to evaluate the predictive accuracy of IRIS™ during...